Ultrasonography-Guided Anticoagulation After DVT

Determining the duration of anticoagulation following an episode of deep vein thrombosis (DVT) can be tricky. To do so, providers must weigh the risk of recurrent venous thromboembolism (VTE) after therapy discontinuation against the increased potential for bleeding complications with prolonged therapy. And the current standard of three to six months for patients with no permanent risk factors has not sufficiently addressed the problem of recurrent VTE, say researchers from the Ultrasound Findings to Adjust the Duration of Anticoagulation in Patients with Deep Vein Thrombosis (AESOPUS) Study.